Published in J Clin Invest on October 01, 1997
Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell (1999) 2.82
Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol (2003) 2.19
Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J Cell Biol (1999) 1.89
A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction. J Cell Biol (2001) 1.84
Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein. J Cell Biol (2000) 1.82
Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle. Proc Natl Acad Sci U S A (2006) 1.68
Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol (1999) 1.24
Dystrophic muscle in mice chimeric for expression of alpha5 integrin. J Cell Biol (1998) 1.18
Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages. J Cell Biol (2007) 1.15
Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation. J Signal Transduct (2011) 1.14
alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J Cell Biol (1999) 1.13
Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells. J Cell Biol (1998) 1.09
Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skelet Muscle (2011) 1.08
Laminin-111 restores regenerative capacity in a mouse model for alpha7 integrin congenital myopathy. Am J Pathol (2008) 1.08
Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy. Am J Pathol (2012) 1.02
Increasing alpha 7 beta 1-integrin promotes muscle cell proliferation, adhesion, and resistance to apoptosis without changing gene expression. Am J Physiol Cell Physiol (2007) 1.01
Dystrophin glycoprotein complex-associated Gbetagamma subunits activate phosphatidylinositol-3-kinase/Akt signaling in skeletal muscle in a laminin-dependent manner. J Cell Physiol (2009) 1.00
Integrin alpha 7 beta 1 in muscular dystrophy/myopathy of unknown etiology. Am J Pathol (2002) 0.98
The dystrophin-glycoprotein complex in the prevention of muscle damage. J Biomed Biotechnol (2011) 0.97
Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency. PLoS One (2010) 0.96
Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A. J Cell Sci (2011) 0.92
Laminin-211 in skeletal muscle function. Cell Adh Migr (2012) 0.92
Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy. Biochim Biophys Acta (2011) 0.91
β1 integrin gene excision in the adult murine cardiac myocyte causes defective mechanical and signaling responses. Am J Pathol (2012) 0.91
Cib2 binds integrin alpha7Bbeta1D and is reduced in laminin alpha2 chain-deficient muscular dystrophy. J Biol Chem (2008) 0.91
Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice. EMBO Mol Med (2011) 0.91
β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice. Hum Mol Genet (2011) 0.91
Integrins protect cardiomyocytes from ischemia/reperfusion injury. J Clin Invest (2013) 0.90
Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice. Hum Mol Genet (2011) 0.88
Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy. Hum Mol Genet (2013) 0.86
Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy. Neuromuscul Disord (2007) 0.85
Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations. BMC Neurol (2005) 0.83
Suppression of anoikis in human intestinal epithelial cells: differentiation state-selective roles of α2β1, α3β1, α5β1, and α6β4 integrins. BMC Cell Biol (2013) 0.81
Hanging on for the ride: adhesion to the extracellular matrix mediates cellular responses in skeletal muscle morphogenesis and disease. Dev Biol (2015) 0.81
Interaction of merosin (laminin 2) with very late activation antigen-6 is necessary for the survival of CD4+ CD8+ immature thymocytes. Immunology (2000) 0.80
Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle. Mol Cell Proteomics (2014) 0.79
Hedgehog signaling and laminin play unique and synergistic roles in muscle development. Dev Dyn (2010) 0.78
The beta1 cytoplasmic domain regulates the laminin-binding specificity of the alpha7X1 integrin. Mol Biol Cell (2003) 0.76
Immobilization of Dystrophin and Laminin α2-Chain Deficient Zebrafish Larvae In Vivo Prevents the Development of Muscular Dystrophy. PLoS One (2015) 0.75
Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice. Sci Rep (2015) 0.75
Integrins: versatility, modulation, and signaling in cell adhesion. Cell (1992) 34.06
RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol (1996) 9.77
Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol (1995) 6.74
Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (1995) 6.35
The extracellular matrix as a cell survival factor. Mol Biol Cell (1993) 6.32
A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol (1993) 5.73
Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell (1990) 5.15
Amino acid sequence of the human fibronectin receptor. J Cell Biol (1987) 4.08
Anchorage dependence, integrins, and apoptosis. Cell (1994) 3.96
Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol (1996) 3.68
Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell (1995) 3.53
Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice. Nat Genet (1996) 3.52
Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet (1996) 3.42
The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform. J Cell Biol (1997) 3.34
Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet (1995) 3.05
The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A (1995) 2.90
Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation. Cell (1987) 2.76
Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem (1995) 2.69
alpha3beta1 Integrin is required for normal development of the epidermal basement membrane. J Cell Biol (1997) 2.46
Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J Biol Chem (1995) 2.35
Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene. Nat Genet (1994) 2.19
Characterization of beta pat-3 heterodimers, a family of essential integrin receptors in C. elegans. J Cell Biol (1995) 2.07
Targeted mutations in cell adhesion genes: what have we learned from them? Dev Biol (1996) 2.05
Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci U S A (1988) 1.98
Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci U S A (1990) 1.93
alpha 3A beta 1 integrin localizes to focal contacts in response to diverse extracellular matrix proteins. J Cell Sci (1995) 1.88
Synthesis of type IV collagen and laminin in cultures of skeletal muscle cells and their assembly on the surface of myotubes. Dev Biol (1982) 1.82
A role for integrin in the formation of sarcomeric cytoarchitecture. Cell (1990) 1.81
Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci (1996) 1.80
A synaptic localization domain in the synaptic cleft protein laminin beta 2 (s-laminin) Science (1995) 1.72
Integrins, adhesion and apoptosis. Trends Cell Biol (1997) 1.72
Apoptosis meets signal transduction: elimination of a BAD influence. Cell (1996) 1.63
Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells. J Cell Biol (1996) 1.57
Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem (1994) 1.56
A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA. J Cell Biol (1996) 1.55
Integrin alpha subunit ratios, cytoplasmic domains, and growth factor synergy regulate muscle proliferation and differentiation. J Cell Biol (1996) 1.52
Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet (1993) 1.50
Identification of a novel mutant transcript of laminin alpha 2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice. Hum Mol Genet (1995) 1.49
Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci U S A (1994) 1.46
Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival. J Cell Biol (1996) 1.42
An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain. J Biol Chem (1992) 1.38
A new isoform of the laminin receptor integrin alpha 7 beta 1 is developmentally regulated in skeletal muscle. J Biol Chem (1993) 1.37
Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci (1995) 1.35
Proteolytic processing of endogenous and recombinant beta 4 integrin subunit. J Cell Biol (1992) 1.34
Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. J Cell Sci (1995) 1.33
Expression of alpha 7 integrin cytoplasmic domains during skeletal muscle development: alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases. J Cell Sci (1993) 1.32
Expression and functional analysis of a cytoplasmic domain variant of the beta 1 integrin subunit. J Cell Biol (1993) 1.32
Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci (1993) 1.29
Synaptic integrins in developing, adult, and mutant muscle: selective association of alpha1, alpha7A, and alpha7B integrins with the neuromuscular junction. Dev Biol (1996) 1.27
Control of integrin expression by extracellular matrix. J Biol Chem (1995) 1.20
In vitro and in vivo expression of alpha 7 integrin and desmin define the primary and secondary myogenic lineages. Dev Biol (1993) 1.19
Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. J Cell Sci (1996) 1.18
Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci U S A (1994) 1.18
Domains of laminin. J Cell Biochem (1996) 1.17
Muscle-eye-brain disease: a neuropathological study. Ann Neurol (1997) 1.12
Cell adhesion to extracellular matrix regulates the life cycle of integrins. Mol Biol Cell (1995) 1.11
Alpha 7 beta 1 integrin is a component of the myotendinous junction on skeletal muscle. J Cell Sci (1993) 1.11
Specific induction of cell motility on laminin by alpha 7 integrin. J Biol Chem (1996) 1.09
Extrasynaptic location of laminin beta 2 chain in developing and adult human skeletal muscle. Am J Pathol (1997) 1.07
Integrin-dependent signal transduction. J Cell Biochem (1996) 1.04
Molecular cloning of the cDNA encoding human laminin A chain. Matrix (1991) 1.03
Intracellular signals direct integrin localization to sites of function in embryonic muscles. J Cell Biol (1996) 1.01
Laminin-induced clustering of dystroglycan on embryonic muscle cells: comparison with agrin-induced clustering. J Cell Biol (1997) 0.99
Merosin/laminin-2 and muscular dystrophy. Neuromuscul Disord (1996) 0.98
Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy. Neuromuscul Disord (1997) 0.92
Expression of laminin subunits in human fetal skeletal muscle. Histochem J (1995) 0.91
Expression of laminin chains during myogenic differentiation. J Biol Chem (1994) 0.91
Sarcoglycan complex is selectively lost in dystrophic hamster muscle. Am J Pathol (1995) 0.90
Laminin beta 2 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy). Neurology (1995) 0.88
Alpha v and alpha 3 integrin subunits are associated with myofibrils during myofibrillogenesis. J Cell Sci (1995) 0.88
Structural organization of the human and mouse laminin beta2 chain genes, and alternative splicing at the 5' end of the human transcript. J Biol Chem (1996) 0.86
The extracellular matrix of skeletal muscle. Coll Relat Res (1985) 0.84
Laminins. Methods Enzymol (1994) 0.84
Mouse adhalin: primary structure and expression during late stages of muscle differentiation in vitro. Biochem Biophys Res Commun (1997) 0.84
Disruption of muscle basal lamina in congenital muscular dystrophy with merosin deficiency. Neurology (1996) 0.83
Muscular dystrophy. Utrophin to the rescue. Nature (1996) 0.81
Abnormal expression of laminin suggests disturbance of sarcolemma-extracellular matrix interaction in Japanese patients with autosomal recessive muscular dystrophy deficient in adhalin. J Clin Invest (1994) 0.80
Basement membrane abnormality in merosin-negative congenital muscular dystrophy. Acta Neuropathol (1996) 0.79
Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol (1972) 40.51
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science (2001) 24.48
Mitochondria and apoptosis. Science (1998) 23.41
Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry (1971) 21.72
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell (1995) 14.90
Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer (1977) 11.99
Regulation of cell death protease caspase-9 by phosphorylation. Science (1998) 11.26
IAP family proteins--suppressors of apoptosis. Genes Dev (1999) 9.96
Mitochondrial control of cell death. Nat Med (2000) 9.17
X-linked IAP is a direct inhibitor of cell-death proteases. Nature (1997) 8.26
Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol (1999) 7.72
Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science (1997) 7.31
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene (1994) 7.24
Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science (1999) 6.77
Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A (1998) 6.69
Apoptosis in the failing human heart. N Engl J Med (1997) 6.35
Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol (1999) 6.24
Enzyme immunoassay ELISA and EMIT. Methods Enzymol (1980) 6.16
Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell (2001) 6.00
Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res (1993) 5.83
A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol (1999) 5.58
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science (1999) 5.53
IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res (1998) 5.41
IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J (1998) 5.28
Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol (1986) 5.22
Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignancies. Leukemia (1999) 5.02
Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science (1998) 4.84
Fibronectin: current concepts of its structure and functions. Coll Relat Res (1981) 4.82
Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature (1993) 4.81
Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science (1986) 4.79
Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell (2001) 4.73
The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J (1997) 4.66
Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell (2001) 4.62
TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell (2001) 4.60
Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science (2000) 4.57
A prokaryotic voltage-gated sodium channel. Science (2001) 4.56
Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell (1995) 4.53
Fibronectin: purification, immunochemical properties, and biological activities. Methods Enzymol (1982) 4.45
Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill (2013) 4.44
Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science (1999) 4.43
Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet (1998) 4.38
Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell (1994) 4.32
The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev (1998) 4.29
Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Blood (1998) 4.07
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A (1997) 4.07
Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell (1996) 4.04
Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature (1993) 4.00
Anchorage dependence, integrins, and apoptosis. Cell (1994) 3.96
Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol (2001) 3.86
Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A (1998) 3.85
Intraneuronal Abeta42 accumulation in human brain. Am J Pathol (2000) 3.83
TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem (1997) 3.81
Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron (2000) 3.73
Clinical evaluation of cerebral oxygen balance during cardiopulmonary bypass: on-line continuous monitoring of jugular venous oxyhemoglobin saturation. Anesth Analg (1992) 3.72
Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol (1994) 3.66
Function of GATA transcription factors in preadipocyte-adipocyte transition. Science (2000) 3.60
CDKN2A mutations in multiple primary melanomas. N Engl J Med (1998) 3.52
Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J (1999) 3.51
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med (1988) 3.50
Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell (2001) 3.49
Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med (1978) 3.46
Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci U S A (1997) 3.45
Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab (2001) 3.43
Bcl-2 family proteins and cancer. Oncogene (2008) 3.42
Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest (1996) 3.42
Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A (1997) 3.37
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet (2000) 3.25
Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. Proc Natl Acad Sci U S A (1986) 3.21
Fas-induced caspase denitrosylation. Science (1999) 3.21
Caspase-9 can be activated without proteolytic processing. J Biol Chem (1999) 3.20
Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol (2000) 3.20
Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Proc Natl Acad Sci U S A (1986) 3.19
Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. Clin Pharmacol Ther (2012) 3.16
Differential regulation of circadian pacemaker output by separate clock genes in Drosophila. Proc Natl Acad Sci U S A (2000) 3.11
Isolation of mutants of Schizosaccharomyces pombe unable to synthesize cadystin, small cadmium-binding peptides. Biochem Biophys Res Commun (1988) 3.09
Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell (1998) 3.09
Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem (1986) 3.06
FAP-1: a protein tyrosine phosphatase that associates with Fas. Science (1995) 3.06
The human laminin receptor is a member of the integrin family of cell adhesion receptors. Science (1988) 3.03
Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res (1994) 3.02
An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem (1999) 2.97
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol (1996) 2.97
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med (2000) 2.96
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood (1993) 2.96
Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity (1998) 2.95
Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat Neurosci (2000) 2.95
Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem (1998) 2.93
The emerging role of electronic medical records in pharmacogenomics. Clin Pharmacol Ther (2011) 2.93
BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J (1997) 2.91
The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A (1995) 2.90
Human RNase III is a 160-kDa protein involved in preribosomal RNA processing. J Biol Chem (2000) 2.88
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res (2000) 2.86
Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins. Cell Death Differ (2006) 2.85
Central melanocortin receptors regulate insulin action. J Clin Invest (2001) 2.83
The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med (1997) 2.83
A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science (1990) 2.80
Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet (1991) 2.79
Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J Biol Chem (1996) 2.79